Perspective Therapeutics (CATX) Other Operating Expenses (2010 - 2024)
Perspective Therapeutics recorded quarterly Other Operating Expenses of -$27000.0 in Q4 2024, down 222.73% quarter-over-quarter from $22000.0 in Q4 2023, and down 222.73% year-over-year from $22000.0 in Q1 2024.
Perspective Therapeutics' Other Operating Expenses history runs 15 years deep, the most recent figure standing at -$27000.0 for Q4 2024.
- In Q4 2024, Other Operating Expenses fell 222.73% year-over-year to -$27000.0; the TTM figure through Sep 2025 stood at -$27000.0 (down 222.73% YoY), while the FY2024 annual figure was -$27000.0, changed N/A from the prior year.
- Other Operating Expenses came in at -$27000.0 for Q4 2024 at Perspective Therapeutics, down from $22000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $1.6 million in Q1 2022 to a low of -$7.9 million in Q3 2022.
- A 5-year average of -$699153.8 and a median of -$2000.0 in 2021 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses jumped 80400.0% in 2020 and tumbled 1134.3% in 2022, its largest moves.
- Perspective Therapeutics' Other Operating Expenses stood at -$7000.0 in 2020, then jumped by 10971.43% to $761000.0 in 2021, then tumbled by 140.08% to -$305000.0 in 2022, then jumped by 107.21% to $22000.0 in 2023, then sank by 222.73% to -$27000.0 in 2024.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$27000.0, $22000.0, and -$22000.0 for Q4 2024, Q4 2023, and Q1 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -27,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Mar 31, 2023 | -22,000.00 |
| Dec 31, 2022 | -305,000.00 |
| Sep 30, 2022 | -7.87 Mn |
| Jun 30, 2022 | -5.31 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Sep 30, 2021 | 761,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | -7,000.00 |
| Sep 30, 2020 | 581,000.00 |
| Jun 30, 2020 | 690,000.00 |
| Mar 31, 2020 | 805,000.00 |
| Dec 31, 2019 | 666,000.00 |
| Sep 30, 2019 | 742,000.00 |
| Mar 31, 2019 | 1,000.00 |
| Dec 31, 2018 | 23,000.00 |
| Sep 30, 2018 | 649,000.00 |
| Jun 30, 2018 | 680,000.00 |
| Mar 31, 2018 | 692,000.00 |
| Dec 31, 2017 | 674,000.00 |
| Sep 30, 2017 | 614,000.00 |
| Jun 30, 2017 | 1.01 Mn |
| Mar 31, 2017 | 530,000.00 |
| Dec 31, 2016 | 448,000.00 |
| Sep 30, 2016 | 524,000.00 |
| Jun 30, 2016 | 63,000.00 |
| Mar 31, 2016 | 301,000.00 |
| Dec 31, 2015 | 254,000.00 |
| Sep 30, 2015 | 278,000.00 |
| Jun 30, 2015 | 455,598.00 |
| Mar 31, 2015 | 374,876.00 |
| Dec 31, 2014 | 303,783.00 |
| Sep 30, 2014 | 353,743.00 |
| Jun 30, 2014 | 303,515.00 |
| Mar 31, 2014 | 245,558.00 |
| Dec 31, 2013 | 326,467.00 |
| Sep 30, 2013 | 359,185.00 |
| Jun 30, 2013 | 367,187.00 |
| Mar 31, 2013 | 290,812.00 |
| Dec 31, 2012 | 322,094.00 |
| Sep 30, 2012 | 316,056.00 |
| Jun 30, 2012 | 338,031.00 |
| Mar 31, 2012 | 259,010.00 |
| Dec 31, 2011 | 304,120.00 |
| Sep 30, 2011 | 264,418.00 |
| Jun 30, 2011 | -21,962.00 |
| Mar 31, 2011 | 179,088.00 |
| Dec 31, 2010 | 185,733.00 |
| Sep 30, 2010 | 373,425.00 |